When was Olink founded?

Olink was founded in 2004 and raised its 1st funding round 11 years after it was founded.

Where is Olink located?

Olink is headquartered in Uppsala, Sweden. It is registered at Matawan, New Jersey.

How many employees does Olink have?

As of Jul 31, 2026, the latest employee count at Olink is 554.

Is Olink a funded company?

Olink is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 01, 2015.

When was the latest funding round of Olink?

Olink's latest funding was a $***** Grant (prize money) round on Dec 01, 2022, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In Sweden, the Life Sciences Platforms and Tools sector has seen $42.2M in funding in 2026 to date.

Where does Olink rank among its competitors?

Olink ranks 4th amongst 83 active competitors, of which 14 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was ProAxsis, which secured $299K in Jul, 2025.

Who are the top competitors of Olink?

Olink's top competitors include Spear Bio, US BioTek Laboratories and Accellix. Among them, ProAxsis secured the most recent funding round in July, 2025.

Olink - 2026 Company Profile, Funding & Competitors

Olink is an acquired company based in Uppsala (Sweden), founded in 2004. It operates as a Provider of products and services for human protein biomarker research and development. Olink has raised an undisclosed amount in funding. The company has 83 active competitors, including 14 funded and 12 that have exited. Its top competitors include companies like Spear Bio, US BioTek Laboratories and Accellix.

Company Details

Provider of products and services for human protein biomarker research and development. The novel tools enable researchers to see further into biology revealing new insights into basic science, drug development, and diagnostics. The company's proprietary product lines include Duolink, a reagent kit for visualization and quantification of individual proteins, their interactions, and modifications, in unmodified cells and tissues; and Pro seek, a reagent kit for protein biomarker detection.

Website: olink.com
Social
Registered Address: Matawan, New Jersey

Key Metrics

Founded Year

2004

Location

Uppsala, Sweden

Stage

Acquired

Latest Funding Round

Grant (prize money), Dec 01, 2022, $*****

Investors

Vitruvian Partners & 6 more

Ranked

4^th among 83 active competitors

Employee Count

554 as on Jul 31, 2026

Investment & Acquisitions

Agresera

Similar Companies

Spear Bio & 95 more

Exit Details

Acquired by Thermo Fisher Scientific (Oct 17, 2023)

View Olink's full profile

Olink is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OLINK PROTEOMICS LIMITED CIN: 9812227 , United Kingdom, Active	Oct 05, 2015	£0 - £1M (As on Dec 31, 2021)	34 (As on Dec 31, 2024)
OLINK PROTEOMICS INC CIN: 473642478 , United States, Active	Dec 31, 1999	-	153 (As on Dec 31, 2024)	-

Olink got acquired by Thermo Fisher Scientific on Oct 17, 2023 at an acquisition amount of $*****.

Click here to take a look at Olink's acquisition in detail

Olink has raised funding over 3 rounds. Its first funding round was on Sep 01, 2015. Its latest funding round was a Grant (prize money) round on Dec 01, 2022 for $*****. 1 investor participated in its latest round. Olink has 7 institutional investors.

Here is the list of recent funding rounds of Olink:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2022	8775201	Grant (prize money)	7122925	7694017	6992014	4913782
Mar 13, 2019	8492471	Conventional Debt	3173336	4349235	2032555	EQT
Sep 01, 2015	7964747	Grant (prize money)	6750623	6555922	5802153	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Olink's funding rounds and investors

Olink's employee count trend

Olink has 554 employees as of Jul 26. Here is Olink's employee count trend over the years:

Uncover Olink's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Olink include Spear Bio, US BioTek Laboratories and Accellix. Here is the list of Top 10 competitors of Olink, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Spear Bio 2021, Boston (United States), Series A	Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers	$49M	Foresite Capital, CDH & 5 others	62/100
2nd	US BioTek Laboratories 2008, Shoreline (United States), Acquired	Provider of enzyme-linked immunosorbent assay technology services	$19.5M	Capitala Group, Pike Street Capital	60/100
3rd	Accellix 2007, San Jose (United States), Acquired	Developer of immunotherapy-based assay delivery platform	$35.8M	Axcel, BioMerieux & 2 others	59/100
4th	Olink 2004, Uppsala (Sweden), Acquired	Provider of products and services for human protein biomarker research and development	-	Vitruvian Partners, EQT & 5 others	53/100
5th	SurModics 1979, Eden Prairie (United States), Acquired	Manufacturer of medical device coatings specialty polymers and diagnostic materials	-	-	53/100
6th	ProAxsis 2013, Belfast (United Kingdom), Acquired	Developer of diagnostic test for the detection of respiratory conditions	$2.79M	Northern Ireland Science, NetScientific & 5 others	52/100
7th	Presage Biosciences 2008, Seattle (United States), Series E	Translational oncology company pioneering drug development with its CIVO platform	$35M	Celgene, Takeda & 6 others	47/100
8th	Correlia Biosystems 2013, Berkeley (United States), Series A	Developer of immunoassay platforms to quantify proteins for proteomics and pharmaceutical applications	$10.9M	Neotribe, Pangaea Ventures & 12 others	45/100
9th	Immunicom 2013, San Diego (United States), Series B	Developer of a immunotherapy device	$21.9M	Gurukul Venture Partners, Cybernaut Zfounder Ventures ... & 4 others	43/100
10th	Biosensia 2006, Dublin (Ireland), Acquired	Point-of-care in vitro diagnostics for immunoassays	$10M	Seroba Lifesciences, Act Venture Capital & 4 others	42/100